Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 1 5Phase 3 4Phase 1/2 4Phase NA 1Phase 4 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 4Dermatologic 2Other solid neoplasm 1Other hematologic neoplasm 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Radiotherapy 26Standard of Care 25Surveys and Questionnaires 22Blood Specimen Collection 21Cisplatin 20Radiotherapy, Intensity-Modulated 19Magnetic Resonance Spectroscopy 19Biopsy 15Practice Guidelines as Topic 13Low-Level Light Therapy 13Exercise 10X-Rays 9Surgical Procedures, Operative 9Radiosurgery 9Interviews as Topic 9Therapeutics 8Magnetic Resonance Imaging 8Saline Solution 7Radiofrequency Ablation 7Radiation 7Fluorodeoxyglucose F18 7Transcutaneous Electric Nerve Stimulation 6Thyroidectomy 6Immunohistochemistry 6Educational Status 6Control Groups 6Chemoradiotherapy 6Cetuximab 6Biopsy, Fine-Needle 6Acupuncture Therapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Immune Checkpoint Inhibitors × Head & Neck × Clear all
NCT06190275 2026-04-24

Clinical Study of GT201 in Combination With PD-1 Inhibitor for Advanced Head and Neck Tumors

Grit Biotechnology

Phase NA Recruiting
32 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon âš¡